Dechra Pharmaceuticals PLC
21 September 2007
Issued by Citigate Dewe Rogerson Limited, Birmingham
Date: Friday, 21 September 2007
Dechra(R) Pharmaceuticals PLC
(the 'Company' or the 'Group')
Annual Information Update
Annual Information Update for the 12 months up to and including 21 September
2007. The Company provides the following information update in accordance with
Prospectus Rule 5.2.
1. RNS Announcements
Further details on the information contained within the RNS announcements listed
below can be viewed on the London Stock Exchange website:
www.londonstockexchange.com under code: DPH.
Date of announcement RNS Headline
18-Sep-07 Annual Report and Accounts
17-Sep-07 Blocklisting Interim Review
17-Sep-07 Blocklisting Interim Review
17-Sep-07 Blocklisting Interim Review
13-Sep-07 Additional listing
04-Sep-07 Development Update
04-Sep-07 Final Results
15-Aug-07 Notice of Results
31-Jul-07 Total Voting Rights
10-Jul-07 Trading Update
29-Jun-07 Total Voting Rights
28-Jun-07 Company Secretary Change
15-Jun-07 Holding(s) in Company
08-Jun-07 Holding(s) in Company
31-May-07 Total Voting Rights
15-May-07 Dechra US Agreement
14-May-07 Holding(s) in Company
30-Apr-07 Total Voting Rights
27-Apr-07 Acquisition
16-Apr-07 Holding(s) in Company
16-Apr-07 Holding(s) in Company
02-Apr-07 Total Voting Rights
27-Mar-07 Holding(s) in Company
22-Mar-07 Additional Listing
20-Mar-07 Blocklisting Interim Review
20-Mar-07 Blocklisting Interim Review
14-Mar-07 Holding(s) in Company
27-Feb-07 Interim Results
15-Feb-07 Holding(s) in Company
23-Jan-07 Holding(s) in Company
15-Jan-07 Total Voting Rights
08-Jan-07 Trading Update
22-Dec-06 Holding(s) in Company
22-Dec-06 Director/PDMR Shareholding
21-Dec-06 Acquisition
19-Dec-06 Total Voting Rights
04-Dec-06 Holding(s) in Company
03-Nov-06 Holding(s) in Company
30-Oct-06 Holding(s) in Company
25-Oct-06 Director/PDMR Shareholding
18-Oct-06 AGM Statement
11-Oct-06 Holding(s) in Company
28-Sept-06 Annual Information Update
2. Documents filed at Companies House
All of the documents listed below were filed with the Registrar of Companies in
England and Wales.
Copies of all documents filed with the Registrar of Companies can be obtained
from Companies House, Crown Way, Cardiff CF14 3UZ or through the website
www.companieshouse.gov.uk.
Date Document filed
10-Aug-07 Form 88(2) - allotment of shares
10-Aug-07 Form 88(2) - allotment of shares
11-Jul-07 Form 288b -resignation of secretary
11-Jul-07 Form 288a - appointment of secretary
05-Jun-07 Form 363 - annual return
24-May-07 Form 88(2) - allotment of shares
13-Feb-07 Form 88(2) - allotment of shares
13-Feb-07 Form 88(2) - allotment of shares
11-Dec-07 Accounts for the year ended 30 June 2007
10-Dec-07 Form 88(2) - allotment of shares
25-Oct-07 Special resolution passed at the AGM
3. Documents published or sent to shareholders
The Company's Annual Report for the year ended 30 June 2007 and Notice of the
2007 Annual General Meeting (which was filed with the UKLA Document Viewing
Facility on 18 September 2007) can be found on the Company website (
www.dechra.com), as can the Interim Report 2006 published in February 2007.
In accordance with Prospectus Rule 5.2.7, we confirm that to the best of our
knowledge, the information relating to the Company referred to above is up to
date at the date of the announcement but it is acknowledged that such
disclosures may, at any time, become out of date, due to changing circumstances.
A copy of this Annual Information Update and copies of the documents referred to
in it can be obtained from the Company Secretary at the Company's registered
office:
Dechra House
Jamage Industrial Estate
Talke Pits
Stoke on Trent
ST7 1XW
Enquiries:
Zoe Bamford, Company Secretary
Dechra Pharmaceuticals PLC
Tel: +44 (0) 1782 771100
Trade Marks appear throughout this release in italics. Dechra and the Dechra 'D'
logo are registered Trade Marks of Dechra Pharmaceuticals PLC
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.